Medical Director/Senior Research Scientist
M.D., University of Padua, Italy
Phone: 410-837-3977 ext. 276
Dr. Schwartz, FRI’s Medical Director, is a psychiatrist and former Director of the Division of Alcohol and Drug Abuse in the Department of Psychiatry at the University of Maryland School of Medicine. His research interests include entry and engagement in drug abuse treatment, pharmacotherapy of opioid dependence in community and in criminal justice settings, and screening and brief intervention for drug misuse in primary care settings. He has served as Principal Investigator (PI) of numerous National Institute on Drug Abuse (NIDA) funded clinical trials. Currently, Dr. Schwartz is PI of a NIDA and Arnold Foundation-funded study of methadone treatment and patient navigation in jail. Dr. Schwartz is the Multi-PI along with Dr. Maxine Stitzer from Johns Hopkins University for the Mid-Atlantic Node of the NIDA Clinical Trials Network. He has over 150 scientific publications, is the winner of the Dole-Nyswander Award from the American Association for the Treatment of Opioid Dependence, and is the Chair of the Substance Abuse and Mental Health Services Administration’s Toolkit for Improving Practice (TIP) on Medications for the Treatment of Opioid Use Disorder.